New hope for PMR sufferers: drug combo aims to reduce steroid use
NCT ID NCT07286214
First seen Jan 05, 2026 · Last updated May 21, 2026 · Updated 26 times
Summary
This study tests whether adding the drug sarilumab to a slow steroid taper helps people with early polymyalgia rheumatica (PMR) achieve lasting remission. About 300 adults aged 50 and older with newly diagnosed or early relapsing PMR will receive either a low or high dose of sarilumab or a placebo, plus a 52-week steroid reduction plan. The goal is to see if sarilumab can control the disease better than steroids alone, while reducing long-term steroid side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research of West Florida - Phase I Unit- Site Number : 8400024
RECRUITINGClearwater, Florida, 33765, United States
-
Denver Arthritis Clinic - Lowry- Site Number : 8400001
RECRUITINGDenver, Colorado, 80230, United States
-
Innovia Research Center- Site Number : 8400029
RECRUITINGMiramar, Florida, 33027, United States
-
Vantage Clinical Trials - Tampa- Site Number : 8400064
RECRUITINGTampa, Florida, 33614, United States
-
Vitalia Medical Research - Margate- Site Number : 8400021
RECRUITINGMargate, Florida, 33063, United States
Conditions
Explore the condition pages connected to this study.